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coefficientAbstract Purpose: We assessed the value of adding Diffusion-weighted (DW) sequences to con-
ventional MR in the diagnostic adrenal algorithm, particularly in patients with indeterminate adrenal
mass.We compared the predictive capabilities of apparent diffusion coefficient values (ADC), lesion size
and signal drop on chemical shift MRI (CS MRI) for differentiating benign and malignant lesions.
Materials and methods: Fifty-five patients with 59 adrenal lesions were evaluated. Lesion size, signal
loss on CSMRI and ADCs were assessed. Sensitivity, specificity and accuracy were calculated for
each parameter. We compared the predictive capability of ADC, CS signal drop, and lesion size
for malignancy with receiver operating characteristic (ROC) curves.
Results: Considering all lesion subtypes, ADC values showed overlap. Benign and malignant
masses had statistically different mean ADCs, with greater mean ADC values in benign lesions
(1.78 ± 0.5 versus 0.97  103 mm2/s ± 0.3). ADC had the lowest accuracy (71.2%) but highest
specificity (100%). Lack of signal drop had the greatest sensitivity (100%); lesion size was the most
accurate (88.1%). On ROC curves, ADC had the lowest prediction for malignancy.
Conclusion: Lesion size and signal drop were stronger predictors of adrenal malignancy than ADC.
ADC shows poor significance in individual cases due to overlapping values.
 2016 The Egyptian Society of Radiology andNuclearMedicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
With the frequent use of cross-sectional imaging to investigate
many abdominal diseases, adrenal gland abnormalities are
being more commonly encountered, the commonest adrenalnodule being a non-hyper functioning cortical adenoma
(1,2). For a cancer patient with an adrenal lesion, definitive
diagnosis of an adrenal metastasis will affect management of
the primary malignancy (3). Therefore accurate characteriza-
tion of these masses and proper differentiation between malig-
nant and benign lesions is essential because the nature of the
mass may have a profound effect on patient’s care and would
obviate both percutaneous biopsy and repeated interval
follow-up imaging (4).
Multiple imaging modalities have been used to characterize
adrenal lesions and the primary purpose is a non-invasive dif-
ferentiation of benign from malignant lesions. Although CT
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Fig. 1 Flowchart of the patients in our study group. RCC= renal cell carcinoma, HCC= hepatocellular carcinoma.
Table 1 Mean values and range of ADC values in benign and
malignant adrenal lesions.
Adrenal lesions Number ADC values (103 mm2/s)
Mean
± SD
Interquartile
range
Benign 34 1.78 ± 0.5 1.4–2.6
Lipid-rich adenoma 18 1.4 ± 0.3 1.04–1.9
Lipid-poor adenoma 6 1.5 ± 0.2 1.2–1.61
Myelolipoma 4 1.6 ± 0.1 1.38–1.65
Pheochromocytoma 3 1.8 ± 1 1.11–3
Cyst 3 2.6 ± 0.2 2.5–2.86
Malignant 25 0.97 ± 0.3 0.59–1.2
Lymphoma 2 0.59 0.58–0.6
Plasmacytoma 1 1.12
Metastases 22 1.2 ± 0.4 0.66–1.95
Note – ADC= apparent diffusion coefficient.
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cially when it comes to lipid-rich adenomas, it is well known
that a subset of these lesions and other adrenal pathologies
remain indeterminate and drawing a clear diagnosis is not
always possible (5).
Therefore another MRI technique characterizing suprare-
nal lesions would be useful. With developing ultrafast MR
imaging techniques, diffusion-weighted imaging (DWI) can
detect specific microvascular and cellular properties in abdom-
inal and pelvic organs (6). DWI gives information on tissue
cellularity and integrity of cell membrane based on the mea-
surement of thermally induced random molecular motion in
biologic tissues, which is known as Brownian motion (7). With
apparent diffusion coefficient (ADC) measurements, DWI can
help in the distinction of benign from malignant adrenal
masses. Generally, there is greater restriction of diffusion in
solid tumor tissues than non-tumoral tissues, which is seenas tumoral tissue exhibiting high signal intensity on DWI
and decreased ADCs. This has been explained by increased
amounts of membranes, cellularity, cytoskeletal components,
organelles and macromolecules in neoplastic tissues (3,8–10).
The aim of our presented work was to assess the value of
adding DWI sequences to conventional MR imaging in the
diagnostic adrenal algorithm, particularly in patients with an
indeterminate adrenal mass. Furthermore, we wanted to com-
pare the predictive capabilities of ADC, lesion size and signal
drop on CSI for differentiating benign and malignant lesions.
2. Patients and methods
2.1. Study population
This study was approved by the hospital ethical committee and
informed consent was obtained from all patients. During two
year duration, we prospectively evaluated 55 patients (27
females and 28 males); they ranged in age between 16 and
66 years (mean ± standard deviation 49.6 ± 12.2). They were
referred for MRI evaluation of adrenal lesions previously
detected by other imaging modalities (Ultrasound (US) and
CT scan). We excluded patients with adrenal lesions smaller
than 1 cm, for which ADC calculations would be inaccurate.
2.2. MRI acquisition
MRI examinations were performed on a 1.5-Tesla MRI system
using two different MRI machines (Intera and Achieva; Philips
Medical Systems, Netherlands) equipped with a phased-array
body coil. All MRI examinations included (a) Axial spin echo
(SE) T1WI (TR/TE: 425/15 ms, matrix 204  256) and (b)
Axial and Coronal fast SE T2 WI, and SE T2 WI with fat sup-
pression (TR/TE: 1800/100 ms, matrix 204  256). The slice
thickness of T1 and T2 sequences was 4 mm with an intersec-
tion gap of 0.4 mm. Respiratory gating was used for SE imag-
ing with flow compensation.
Fig. 2 A 48-year-old woman with right adrenal collision tumor composed of a pheochromocytoma and a lipid-rich adenoma. (a)
Coronal T2 WI image shows an isointense adrenal mass with a hypointense smaller nodule at its periphery (arrow). (b) Axial T1 WI in
phase and (c) out of phase images show signal dropout of the hypointense component on opposed phase image consistent with lipid-rich
adenoma (arrow), while the isointense mass remains isointense with internal hyperintense signal denoting hemorrhagic component. (d)
Axial spin-echo echo-planar diffusion-weighted image (b value, 600) shows restricted diffusion in the solid portion of the mass (arrow). (e)
Axial apparent diffusion coefficient (ADC) map: ADC values were 1.11  103 mm2/s and 1.31  103 mm2/s for the mass and nodule
respectively. Surgical resection was done and pathology revealed an adrenal collision tumor composed of a benign hemorrhagic
pheochromocytoma and adenoma.
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level of the adrenal mass using a T1WI Gradient Recalled
Echo (GRE) sequence with breath holding (TR: 68–160 ms
and TE: 4.9 ms for in phase (IP) images and 6.3 ms for
opposed phase (OP) images). The flip angle was 30, the
matrix size was 128  256 and FOV varied from 320 to
375 cm.
Axial DWI was done with a single-shot spin echo-planar
sequence before administration of contrast material. A gener-
alized autocalibrating partially parallel acquisition was used as
well as an acceleration factor of 2. DWI was acquired during
one or more breath-holds at b values of 0, 600 and 800
s/mm2. The MR imaging parameters were TR/ TE, 5000/80;
matrix, 156  192; bandwidth, 1446 Hz/pixel; section thick-
ness, 6 mm; gap, 1.8 mm and FOV, 300–400 mm.
Finally dynamic axial T1WI was done after intravenous
(IV) administration of 0.1 mmol/kg of Gadopentetate
dimeglumine-DTPA (Magnevist; Schering, Berlin, Germany),with image acquisition in the arterial (30 s), portal (60 s) and
late equilibrium phases (180–300 s).
2.3. Analysis of MRI images
All MRI images were transferred to an independent worksta-
tion (Philips MR extended workspace, software version
2009) and were reviewed and analyzed. Size was recorded with
the MRI distance cursor that measured the largest diameter in
the axial plane on the non-contrast series. Lesions <4 cm were
presumed to be benign, whereas lesions >4 cm were presumed
to be malignant (11).
Qualitative assessment of the CS images was done with a
definite signal drop on OP images considered significant for
benign lesions. The absence of signal drop was considered sig-
nificant for malignant lesions (12).
ADC maps were generated using already available algo-
rithms. We measured ADC values on the ADC map for each
Fig. 3 A 65-year-old man with bronchogenic carcinoma and left
adrenal metastases. (a) Axial T2 WI shows an isointense adrenal
mass with internal cystic changes. (b) Axial spin-echo echo-planar
diffusion-weighted image (b value, 600) shows diffusion restriction
in most of the lesions except for its central portion. (c) Axial
apparent diffusion coefficient (ADC) map: ADC value was
0.9  103 mm2/s. Surgical resection was done and pathology
revealed left adrenal metastatic deposit.
Fig. 4 A 55-year-old woman with bilateral adrenal lymphoma.
(a) Axial T2 WI image shows bilateral large adrenal masses
(arrows) with faint heterogeneous high signal intensity. (b) Axial
apparent diffusion coefficient (ADC) map: Both lesions showed an
ADC value of 0.58  103 mm2/s. Surgical resection was done and
pathology revealed lymphoma.
602 M. El-Kalioubie et al.lesion, with b value of 800 s/mm2 by using circumferential
regions of interest (ROIs). The ROIs were placed at the lesion’s
center, drawn as wide as possible, with exclusion of necrotic
portions and lesion margins.
2.4. Standard of references
The findings of conventional MRI and DWI were compared
with results of histopathology, clinical and imaging follow-
up data (6 months).
2.5. Statistical analysis
The SPSS software (Statistical Package for the Social Science;
SPSS Inc., Chicago, IL, USA), release 21 version for Mac
was used. Data were expressed as mean ± standard deviation
or number/percentage (%). Lesion size and ADC were com-
pared between malignant and benign masses using the unpaired
student t-test. We classified the results of the analysis of MR
Table 2 Statistical assessment of the MRI parameters used in differentiation of benign and malignant adrenal masses.
MRI parameters Accuracy (%) Sensitivity (%) Specificity (%) Chi square P value
Size (cm) 88.1 92 85.3 34.5 <0.001
Signal drop 76.3 100 58.8 22.2 <0.001
ADCs  103 mm2/s 71.2 32 100 12.6 <0.001
Note – MRI = magnetic resonance imaging; ADC= apparent diffusion coefficient.
Diffusion-weighted MRI in adrenal lesions 603images (size, CSI signal drop and ADCs) as true positive, true
negative, false positive or false negative for the diagnosis of
malignant versus benign adrenal lesions. Then standard diag-
nostic indices such as sensitivity, specificity and diagnostic
accuracy were calculated for each parameter. The p values by
Chi-square test were determined: <0.05 = significant,
<0.01 = highly significant and >0.05 = non-significant. The
agreement between ADC and signal drop, and between ADC
and lesion size were analyzed by Cohen’s kappa test. The over-
all predictive power of ADC, signal drop on CSI and lesion size
for distinguishing benign and malignant lesions were assessed
by construction of receiver operating characteristic (ROC)
curves where sensitivity was plotted against 1-specificity and
then calculation of the area under the curve (AUC). Cutoff
ADC values were calculated in order to achieve the highest
average sensitivity and specificity. Lesions were categorized as
being benign if the ADC value exceeded 1.0  103 mm2/s,
and malignant if the ADC value was 61.0  103 mm2/s.3. Results
Fifty-nine adrenal lesions in 55 patients (51 patients had uni-
lateral lesions, three had bilateral lesions and one had double
unilateral lesions) were evaluated in the study.
The final diagnoses of adrenal lesions included 34 benign
lesions (57.6%) and 25 malignant lesions (42.4%). Benign
lesions included lipid-rich adenomas (n= 18, 30.5%), atypical
adenomas (n= 6, 10.2%), myelolipomas (n= 4, 6.8%),
pheochromocytomas (n= 3, 5.1%) and cysts (n= 3, 5.1%),
whereas malignant lesions included the following: lymphoma
(n= 2, 3.4%), plasmacytoma (n= 1, 1.7%) and metastases
(n= 22, 37.3%). The primary sites of tumors for the meta-
static lesions were lung cancer (n= 9), renal cell carcinoma
(RCC) (n= 6), breast cancer (n= 4), hepatocellular carci-
noma (HCC) (n= 2) and Kaposi sarcoma (n= 1). A flow-
chart of the patients in our study is demonstrated in Fig. 1.
A total of 32 lesions (54.2%) were confirmed by pathology.
We had histopathologic proof of diagnosis for all malignant
(n= 25) adrenal lesions. Furthermore 7 benign adrenal lesions
(all 3 pheochromocytomas, 2 lipid-rich adenomas and 2 atyp-
ical adenomas) had histopathologic confirmation.
The rest of the lesions (n= 27, 45.7%) had been followed
up. They were stable over a minimum period of 6 months on
US or CT examinations. Adrenal myelolipomas (n= 4) were
diagnosed by the presence of macroscopic fat with signal sup-
pression on fat-saturated sequences, while the diagnosis of
adrenal cysts (n= 3) was ascertained by dark signal intensity
(SI) on T1, bright SI on T2 and lack of enhancement on
contrast-enhanced images.The rest of benign lesions were diagnosed if stability was
seen on a 6-month follow-up imaging (n= 20, 16 lipid-rich
adenomas and 4 atypical adenomas).
3.1. Size
Benign adrenal lesions ranged from 1 to 11 cm, with a mean
size of 3.5 cm ± 2.2, while malignant adrenal lesions were big-
ger, ranging from 2.2 to 20 cm, with a mean size of 7 cm ± 3.7
(p< 0.001).
3.2. Enhancement
Following dynamic contrast injection, the following patterns
of enhancement were noted: homogenous enhancement in all
lipid rich adenomas, similar pattern for atypical adenomas
with the exception of two lesions that showed heterogenous
enhancement. Heterogenous enhancement was also noted with
pheochromocytomas, metastases, lymphoma and the plasma-
cytoma lesion.
Finally no contrast enhancement occurred with adrenal
myelolipomas or adrenal cysts.
3.3. CSI findings
Twenty (58.8%) out of 34 benign adrenal lesions (18 lesions of
lipid-rich adenoma, and 2 lesions of myelolipoma) showed sig-
nal drop. On the other hand, no signal drop could be detected
in any of the malignant lesions.
3.4. ADC values
The mean ADC values of different adrenal lesion subtypes are
demonstrated in Table 1. Considering all lesion subtypes, there
was an overlap of obtained ADC values. Adrenal cysts had the
greatest median ADC value (2.6  103 mm2/s) in the study
group. For other benign lesions, there was no significant differ-
ence in ADC values. In particular, the ADC measurements of
lipid-rich adrenal adenomas (Fig. 2) did not vary from those of
the atypical lipid-poor adrenal adenomas (P= 0.457).
For the malignant group, the mean ADC value of metas-
tases (Fig. 3) was greater than that of lymphoma (Fig. 4).
The ADC value of the single case of plasmacytoma (Fig. 5)
was close to the mean ADC value of the metastatic lesions.
Statistical significance could not be assessed owing to the lim-
ited number of lymphoma and plasmacytoma lesions.
There was significant difference in the mean ADC value of
benign adrenal lesions compared with malignant adrenal
masses (p< 0.001) with benign lesions showing greater mean
Fig. 5 A 68-year-old man with left adrenal plasmacytoma. (a)
Axial T2 WI image shows a large soft tissue mass infiltrating the
left adrenal gland, left kidney and spleen with heterogenous signal
intensity. (b) Axial spin-echo echo-planar diffusion-weighted
image (b value, 600) shows restricted diffusion of the lesion. (c)
Axial apparent diffusion coefficient (ADC) map: ADC value was
1.2  103 mm2/s. Surgical resection was done and pathology
revealed primary adrenal extramedullary plasmacytoma.
Fig. 6 Receiver operating characteristic (ROC) curves for lesion
size, signal drop on chemical shift imaging (CSI) and apparent
coefficient diffusion (ADC) values for prediction of malignancy in
the adrenal lesions. Area under curve (AUC) for lesion size was
0.886 (95% CI: 0.793–0.980; p< 0.001), AUC for signal drop on
CSI was 0.794 (95% CI: 0.680–0.909; p< 0.001), and AUC for
ADC values was 0.660 (95% CI: 0.512–0.808; p= 0.037).
604 M. El-Kalioubie et al.ADC values (1.78  103 mm2/s/±0.5 versus 0.97  103
mm2/s ± 0.3).
The mean ADC value of adrenal benign lesions after exclu-
sion of adrenal cystic lesions was 1.58  103 mm2/s/±0.2.There was extreme statistical significant difference between
the mean ADC values of adrenal benign solid lesions and adre-
nal malignant lesions.
There was no statistically significant difference between the
ADC values of lipid-poor adenomas (classified as indetermi-
nate lesions on CSI) and metastases (p> 0.05). Pheochromo-
cytomas had higher mean ADC values (1.8  103 mm2/s ± 1)
than adenomas or metastases.
The sensitivity, specificity and accuracy as well as p values
of the MRI parameters for differentiation of malignant and
benign adrenal masses are presented in Table 2. ADC values
had the lowest accuracy (71.2%) and chi square value, but
the highest specificity (100%). Signal drop had the greatest
sensitivity (100%) while lesion size was the most accurate
(88.1%) with the greatest chi square value.
Agreement between ADC and signal drop was poor
(kappa = 0) whether for benign or adrenal malignant lesions.
Similar results were obtained as regards the agreement between
ADC and lesion size.
ROC curves for lesion size, signal drop on CSI and ADC
are demonstrated in Fig. 6.
Lesion size was the greatest predictor of malignant adrenal
lesions and showed an AUC of 0.886 (95% CI: 0.793–0.980;
p< 0.001). This was followed by signal drop on CSI
(AUC= 0.794, 95% CI: 0.680–0.909; p< 0.001). ADC value
had the lowest predictive power, with (AUC= 0.66, 95% CI:
0.512–0.808; p= 0.037) at a cutoff value 61.0  103 mm2/s.
The difference in AUC for lesion size compared with ADC
was 0.226 and was statistically significant (p= 0.013), while
the difference in AUC for signal drop on CSI compared with
ADC was - 0.134 and was not statistically significant
(p= 0.160).
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In this study, we assessed the role of DWI in differentiating
benign from malignant adrenal lesions. We evaluated the fol-
lowing MRI parameters: lesion size, signal drop on CSI and
ADC values.
With a cutoff value of 4 cm for lesion size, the mean axial
diameter of benign lesions (3.5 cm ± 2.2) was significantly
lower than malignant lesions (7 cm ± 3.7) (p< 0.001). This
was in concordance with previous literature findings (3,13).
Lack of signal drop on CS MRI accurately diagnosed all
malignant lesions, by showing the absence of signal drop on
OP images and showing signal loss in 20/43 benign lesions, dis-
tinctively lipid-rich lesions. In a previous study by Inan et al.
(14), there was significant signal loss in 38/48 adenomas
(79.16%), moderate signal loss in 6/48 adenomas (12.5%),
and no definite signal drop in the 4 (8.33%) lipid-poor adeno-
mas. There was no signal loss in any of the malignant masses.
Some adrenal adrenocortical carcinomas have been reported
to contain intracellular lipid (15); however, no cases of adreno-
cortical carcinomas were included in our study population.
We found a significant difference between the mean ADC
measurements of benign and malignant lesions; benign lesions
showed greater mean ADC values (1.78  103 mm2/s versus
0.92  103 mm2/s, p< 0.001). This was in agreement with
the findings of Sandrasegaran et al. (2), who found a signifi-
cant ADC difference between benign and malignant masses
(p= 0.02, 0.01 for the two observers) on univariate analysis.
On the other hand and in contrast to our study, Tsushima
et al. (9) analyzed the DWI criteria of 31 adrenal adenomas,
7 metastases and 5 pheochromocytomas and found no signifi-
cant difference between ADC values of adenomas and metas-
tases. Similarly Isik et al. (5) found no significant difference in
ADCs between adenomas and metastases.
In our study, despite the statistically significant difference in
the mean values of benign and malignant lesions, there was
overall a considerable overlap between the two groups, render-
ing ADC measurements of lower value in individual lesions.
Miller et al. (3) showed considerable overlap of ADC measure-
ments between malignant and benign adrenal lesions.
Adrenal adenomas may contain various amounts of cyto-
plasmic fat (16), therefore displaying different degrees of
restriction to water diffusion (17,18). In our study however,
we did not find a statistically significant difference between
ADC values of lipid-rich and lipid-poor adenomas. Also no
difference was found between adenomas and other benign
lesions including myelolipomas and pheochromocytomas.
Similar to Miller et al. (3) results, ADCs of adrenal cysts
were significantly greater (2.6  103 mm2/s) than the remain-
ing adrenal lesions, a finding also found in previous studies in
other organs cystic lesions (19). Kilickesmez and his colleagues
(20) also reported a mean ADC of 2.82  103 mm2/s ± 0.24
for adrenal cysts. There was extreme statistical significant dif-
ference between the mean ADC values of adrenal benign solid
lesions (after exclusion of adrenal cystic lesions) and adrenal
malignant lesions.
No statistically significant difference was found between
lipid-rich adenomas and metastases or between lipid-poor ade-
nomas classified as indeterminate lesions on CSI and metas-
tases. This was similar to the results of Sandrasegaran et al.
(2) who stated that adding ADC values to assess indeterminatelesions by quantitative CSI was not statistically beneficial. The
assessment of combined SI index and ADC did not yield a sig-
nificant increase in AUC, when it was compared with the AUC
of the SI index alone (0.76–0.80; p= 0.40). The study by
Tsushima et al. (9) suggested that the densely packed cells of
adrenal adenomas could explain the lack of significantly high
ADCs in adenomas compared with metastases.
Similar to Tsushima et al. (9), we found higher mean ADC
value of pheochromocytoma in comparison with adenoma and
metastasis.
ADC measurements could not predict with certainty if indi-
vidual lesions were benign or malignant. We found that both
lesion size and signal loss on CSI showed greater predictive
capability than ADC on ROC curves analysis. The difference
in AUC for size of the lesion compared to ADC was 0.226
and was statistically significant (p= 0.013). The difference in
AUC for signal drop on CSI compared with ADC was
0.134 and was not statistically significant (p= 0.160). Miller
et al. (3) also found a significantly greater AUC for SI index
(0.95) and lesion size (0.82) compared with ADC (0.55). San-
drasegaran et al. (2) stated the AUC for ADC curves was
not statistically different from those of CSI parameters (SI
index, adrenal-to-spleen ratio (ASR)).
We did not find a good agreement between signal drop on
CSI and ADC as regards the diagnosis of either malignant or
benign masses. In the study by Miller et al. (3), there was no
linear correlation between percentage of SI decrease and
ADC values.
Signal drop on CSI had the greatest sensitivity (100%)
while lesion size was the most accurate (88.1%) with the great-
est chi square value. ADC values had the lowest accuracy
(71.2%) and chi square value, but the highest specificity
(100%). The diagnostic capacity of CS MRI for adrenal ade-
nomas has been illustrated by prior studies (21–23). It was pre-
viously reported that the most specific indicators and
predictors of adrenal mass character are the CSI signal drop
on OP images, reflecting lipid content in the lesion and Gd-
DTPA enhancement characteristics. When CSI is excluded
from statistical evaluation of combined MRI diagnostic
parameters, the lowest diagnostic accuracy is obtained (13).
Our study had few limitations. The current sample size had
limited statistical power and allowed us to detect only large
differences in test performance, and another study with bigger
number is recommended. The absence of quantitative assess-
ment of SI variations on OP images was a potential limitation.
However in general practice, qualitative assessment of signal
drop is commonly used (23). Finally, the small number of inde-
terminate lesions after CS imaging in our study group under-
mined the assessment of DWI usefulness and its addition to
the diagnostic tree for this category.
In conclusion, despite a statistically significant difference
between benign and malignant adrenal lesions, considerable
overlap of ADC values is rendering this technique of little
interest in individual cases. Importantly, DWI did not help
in differentiation of lipid-poor and lipid-rich adenomas or
lipid-poor adenomas and metastases, reflecting its poor merit
in indeterminate lesions.
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